European equities traded in the US as American depositary receipts started the week modestly lower late Monday morning, declining 0.26% to 1,486.79 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by internet advertising firm Criteo (CRTO) and biopharmaceutical company Cellectis (CLLS), which rose 1.5% and 1.3%, respectively. They were followed by software firm SAP (SAP) and telecommunications company Ericsson (ERIC), which were up 0.9% and 0.8%, respectively.
The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and biotech firm Evaxion (EVAX), which fell 5.5% and 4.4%, respectively. They were followed by accommodations booking company trivago (TRVG) and semiconductor company Sequans Communications (SQNS), which lost 3.8% and 3.4%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which advanced 5.1% and 2.4%, respectively. They were followed by telecommunications operator Vodafone Group (VOD) and financial services company HSBC (HSBC), which increased 1.8% and 0.9%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics (BCYC) and NuCana (NCNA), which dropped 4.3% and 2.6%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and oil and gas company Shell (SHEL), which were down 2.5% and 2.1%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。